Erlotinib is an EGFR inhibitor, which is used for treating non-small cell lung cancer and pancreatic cancer. It’s mostly for patients who have EGFR mutations. It works by stopping EGFR signaling, which is often what lets cancer cells grow out of control.
Erlotinib comes in three different strengths: 25, 100, and 150 milligrams. The usual dose for most people is 150 mg, taken once a day on an empty stomach if possible. The tablets come in bottles of 30 each.
Erlotinib is mainly used to help slow down or even stop cancer from spreading in patients with specific EGFR mutations that often show up in NSCLC and pancreatic cancer.
